Skip to main content
. 2018 Dec 31;34(4):160–165. doi: 10.5625/lar.2018.34.4.160

Table 1. Brief overview of breast cancer cell line-derived xenograft (CDX), patient-derived xenograft (PDX) and syngeneic mouse models.

Implantation site Mice strain Cell line Subtype ER PR HER2 References
CDX model subcutaneous CDX Subcutaneous BALB/c, Nude MDA-MB-231 Basal [18]
MDA-MB-435 Basal [54]
BT-474 Luminal B + + + [55]
Orthotopic CDX Mammary fat pad NOD/SCID MDA-MB-231 Basal [22]
MDA-MB-435 Basal [23]
SUM1315 Basal [24]
MCF7 Luminal A + + [25]
T47D Luminal A + + [26]
Metastatic CDX Tail vein NOD/SCID MDA-MB-231 Basal [56]
SUM149 Basal [57]
PDX model Subcutaneous BALB/c, Nude [58]
Mammary fat pad NOD/SCID [59]
Mammary fat pad NSG [60]
Humanized Mammary fat pad NOD/SCID [61]
Syngeneic model Mammary fat pad BALB/c 4T1 - - - [38]